The adoption of a life-course immunisation approach in the EU will have significant multi-level effects, ranging from a healthier population to savings in healthcare budgets, Professor Daphné Holt told EURACTIV.com.
Stricter rules on smoking, reimbursed anti-smoking programmes and smoke-free public places are among the ways to prevent chronic obstructive pulmonary disease (COPD) from being a public health crisis, says Mikaela Odemyr.
“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.
The Maltese EU presidency will seek more transparency in the way pharmaceutical companies negotiate with member states on medicines’ pricing, Health Minister Chris Fearne said in an interview with EURACTIV.
Alzheimer’s disease and other forms of dementia remain underdiagnosed in most European countries, Jean Georges told EURACTIV.
A new breed of drugs, called “value added medicines”, could help patients improve their everyday life while in treatment, without increasing healthcare budgets, Christoph Stoller said in an interview with EURACTIV.com
The European Parliament will oppose cuts to the EU health budget for 2014-2020, MEP Antonyia Parvanova (ALDE, Bulgaria) told EURACTIV in an interview. She also says the proposed budget of €50 million per year for 28 member states is too modest.
